PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Astellas Signed an Exclusive License and Development Agreement with Selecta Biosciences for Xork IgG Protease

Astellas Signed an Exclusive License and Development Agreement with Selecta Biosciences for Xork IgG Protease

January 10, 2023

Telemedicine: A New Frontier for Public Health

Telemedicine: A New Frontier for Public Health

January 10, 2023

Ipsen to Acquire Albireo for ~$952M

Ipsen to Acquire Albireo for ~$952M

January 10, 2023

Lydus Medical’s Vesseal Device Receives the US FDA’s Clearance for Small Arteries

Lydus Medical’s Vesseal Device Receives the US FDA’s Clearance for Small Arteries

January 10, 2023

Genentech Bio Signed a Discovery Collaboration with Kronos Bio to Advance Novel Therapies Against Transcriptional Targets in Oncology

Genentech Bio Signed a Discovery Collaboration with Kronos Bio to Advance Novel Therapies Against Transcriptional Targets in Oncol...

January 10, 2023

Arrowhead and Takeda Report P-II Study (SEQUOIA) of Fazirsiran for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

Arrowhead and Takeda Report P-II Study (SEQUOIA) of Fazirsiran for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

January 10, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us